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Effect of Preparation Procedures on Intensity of

Radioautographic Labeling Is Studied 
A report is available which summarizes research 
findings concerning the effects of tissue preparation 
and extractive procedures on the intensity of radio-
autographic labeling. The effects are presented in 
terms of mean grain count per cell in cells labeled with 
tritiated precursors of proteins or nucleic acids. 
Ehrlich ascites tumor cells were labeled in vivo with 
one of three tritiated compounds: thymidine, cytidine, 
or leucine. After 30 minutes the cells were examined 
by radioautography. Carnoy's solution and methanol, 
the most frequently used fixatives in radioautography, 
proved to be reliable, each removing equal amounts of 
radioactivity from the cells. This fixative-soluble 
radioactivity presumably represents the fraction of 
precursor that has not been incorporated into nucleic 
acids or proteins. 
Treatment with ribonuclease or cold perchloric 
acid removed all radioactivity from cells labeled with 
tritiated cytidine, but not from cells labeled with tn-
tiated thymidine. Treatment with deoxyribonuclease 
removed radioactivity incorporated into deoxyribo-
nucleic acid, but affected the ribonucleic acid label to 
a lesser extent. 
A comparison of sections and smears from the same 
sample indicated that, in smears of tritiated leucine 
labeled cells, some of the grains found in the emulsion 
overlying the nucleus are not due to radioactivity in 
the nucleus. They result instead from radioactivity 
present in the thin coat of cytoplasm which lies be-
tweenthe nucleus and the emulsion.
Notes: 
This information would be of interest to medical 
researchers and cytologists. 
Additional information may be found in: 
(a) Laboratory Investigations, Intern. Academy of 
Pathology, vol. 12,' no. 6, p. 648-656, 1963 
(b) Cancer Research, vol. 20, July 1960, p. 910-
917 
(c) Scientific  American, 209, August 1963 
(d)Nature, vol. 202, p. 4931, November 1964 
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Patent status: 
Inquiries about obtaining rights for commercial 
use of this innovation may be made to: 
Mr. George H. Lee, Chief 
Chicago Patent Group 
U.S. Atomic Energy Commission 
Chicago Operations Office 
9800 South Cass Avenue 
Argonne, Illinois 60439
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